What I could have, is this antibody,

With humanized technology we can monitor the quality of your sleep cycles.

They attach the bismuth 213 to an antibody.

Antibody is essentially like a lock and key.

You mix it up with these carbon nanotubes and this antibody.

But in that time, that antibody can go and find a cancer cell.

We saw earlier that HlV is highly variable, that a broad neutralizing antibody

1,000 dollar antibody injections under the skin, by the way, and 20 of them.

And antibody stainings like this one can be used to understand that sort of question.

This, for example, is an antibody staining against serotonin transporters in a slice of mouse brain.

What happens is you just change this antibody in the sensor, you can detect anything, any protein.

And if an antibody is stuck to one of these things on the cell, it means that's food.

They're currently making a cocktail an antibody cocktail that can be used to treat severe, overwhelming cases of flu.

What if we could harness them and convince them to not be an antibody that does something like HlV?

Antibody is basically a lock and key molecule that attaches specifically to a certain protein, in this case, the mesothelin.

This strategy, working backwards from an antibody to create a vaccine candidate, has never been done before in vaccine research.

What I could do is I could put an antibody in this network such that would react specifically to the mesothelin.

The Thai results tell us we can make an AlDS vaccine, and the antibody findings tell us how we might do that.

By switching out that antibody, you can look at a different protein, thus, a different disease potentially any disease in the entire world.

I could essentially lace these nanotubes with the antibody and it would have a network that would react only with that specific protein.

I was rolling around this concept, how could I connect the carbon nanotube's amazing properties to how this antibody reacts with the only protein?

So for instance, a biotechnology company has now found broadly neutralizing antibodies to influenza, as well as a new antibody target on the flu virus.

What happens is when you put a blood sample that contains that target protein in it on this network, that protein will go into the network and form a larger molecule with that antibody.

Now, it sounds easier than it is because the structure actually looks more like this blue antibody diagram attached to its yellow binding site, and as you can imagine, these three dimensional structures are much harder to work on.

And I think that that digital revolution now is coming to the point where, as the virtual world, which brings so many people together here, finally connects with the physical world, there is the reality that that has become humanized, so that digital world has all the friendliness, all the immediacy, the orientation of the analog world.